FDA approval of leucovorin sparks debate over autism treatment efficacy
TL;DR Summary
The FDA has reapproved GSK's leucovorin for treating cerebral folate deficiency, a condition affecting many children with autism, which may lead to increased use of leucovorin-based supplements despite limited evidence of effectiveness for autism treatment.
- FDA’s leucovorin approval could be a boon for supplement makers statnews.com
- What science says about leucovorin, the drug Trump touted for autism CNN
- F.D.A.’s Approval of a Drug for Autism Upends Review Process The New York Times
- Is leucovorin an effective treatment for autism? Here's what research shows NBC News
- Trump's touting of an unproven autism drug surprised many, including the doctor who proposed it AP News
Reading Insights
Total Reads
0
Unique Readers
2
Time Saved
1 min
vs 2 min read
Condensed
84%
224 → 35 words
Want the full story? Read the original article
Read on statnews.com